SYNOPSIS
Since Saffran and Schally (1955 a and b) reported the existence of corticortrophinreleasing factor (CRF) in the posterior pituitary lobe as a neurohumor, a number of workers have presented various methods for assaying CRF. Originally, Saffran and Schally (1955 a) offered an in vitro method, assaying ACTH release from the pituitary in response to various substances.
The in vitro assay method has a great advantage in that the effect of endogenous neurohumor release is completely excluded.
The method, however, has some theoretical and practical shortcomings (Fortier, 1958 a, and b; Fortier and Ward, 1958; Guillemin et al., 1959 b) and the specificity of this method has now been questioned (Barrett and Sayers, 1958) .
In vivo assay methods for CRF have also been widely studied. Pharmacologically, in Nembutal-morphine treated rats the acute effect of stressful stimuli on the rate of ACTH secretion is blocked and the effect of various stressful drugs on the pituitary-adrenal system is suppressed Munson and Briggs, 1955; Guillemin et al., 1959 a) . Destruction of the median eminence has also been found to inhibit the release of ACTH following a wide variety of noxious stimuli.
Rats with the hypothalamus or median eminence lesioned by means of stereotaxic instruments have been used for the assay of CRF (McCann, 1953; Ganong and Hume, 1954; McCann, 1957; de Wied et al., 1958; Slusher, 1958; McCann and Harberland, 1960; de Wied, 1961) . On the other hand, the secretion of ACTH from the adenohypophysis is under negative feed-back control of the adrenocortical hormones. Therefore, a large amount of corticosteroids is capable of inhibiting the effects of pituitary-adrenal activities.
This mechanism has been utilized for the assay of CRF. (McCann, 1957; McCann et al., 1958; de Wied and Mirsky, 1959; Leeman et al., 1962; Rerup, 1964 a; de Wied., 1964; Carbin et al., 1965) .
In this laboratory, it became necessary to estimate corticotrophin-releasing activity quantitavely for the purpose of purifying CRF from the posterior pituitary. At first, the in vitro method of Saffran and Schally and in vivo method of Guillemin (1959 b) were followed, but without satisfactory results. In view of difficulties encountered in other hitherto reported methods when applied to our purpose, a new procedure had to be worked out.
The purpose of the present paper is to describe a new in vivo method for the bioassay of CRF which is simple, easy and suitable as a routine procedure.
MATERIALS AND METHODS
(1 Blood was collected in heparinized beakers from the trunks of rats quickly decapitated 15min. after stress or injection. For determination of the non-stressed resting level of plasma corticosterone, rats were quickly taken from the cage to the next room and was decapitated within 20secs.
Plasma corticosterone determination was carried out according to the method of Zenker and Bernstein (1958) with some modifications. Plasma was separated from heparinized blood by centrifugation at 3,000 r. p. m. for 5 min. and stored in a deep-freezer at-30°C.
One ml aliquot of each plasma was extracted with 30ml of chloroform. The extract, after being washed with 4.0ml of 0.1N NaOH, was added to 3.0ml of 50% ethanol sulfuric acid (1:2.4,v:v (4) Administration of drugs and hormonal preparations Heparin sodium (Novo), 10,000 USP/vial, was dissolved in 50ml of normal saline and 0.1ml aliquot was used for each blood specimen.
Pentobarbital sodium, Nembutal (Abbott), was injected intraperitoneally in a dose of 5.0mg /100g B.W.
Dexamethasone-21-phosphate disodium salt,"Decadron", was injected intraperitoneally at various doses after dilution with normal saline.
Histamine (Sanko Junyaku),/-Epinephrine (Tokyo Kasei) and Serotonine (Nutritional Biochemicals Corporation) were dissolved in normal saline for use.
Synthetic lysine-8 vasopressin was administered intravenously after being diluted to a desired concentration with normal saline.
ACTH, commercial preparation of Organon, was dissolved in normal saline and administered intravenously.
Corticotrophin-releasing factor (CRF) was extracted from the hog posterior pituitary and precipitated with acetone and ether. The preparation was further purified by carboxymethylcellulose chromatography and partition chromatography on "Sephadex" G-25. The partially purified preparation used in the present study still contained a small amount of vasopressin (15.1 IU/mg).
(5) Bioassays ACTH was assayed in Nembutal anesthetized rats (Rerup and Hedner, 1962) or 24-hour hypophysectomized rats.
Hypophysectomy was performed by the transauditory canal method (Koyama, 1962) (2) Effect of dexamethasone in Nembutal-treated rats Effect of various doses of dexamethsone on the adrenal responsiveness to ACTH and inhibition of vasopressin effect were tested. Figure 2 shows that with the increase of dexamethasone dose, the inhibiting effect of corticosteroid on ACTH secretion became more evident. On the contrary, the adrenal responsiveness for the moderate doses of ACTH decreased with an increase in the dose of dexa- methasone. It was found that the most suitable dose of dexamethasone was 0.2mg per 100g body weight when animals were treated with 5.0mg of Nembutal.
In an attempt to investigate the stress-blocking effect of dexamethasone, rats were treated with 0.2mg of dexamethasone and subjected to stress with i.p. Nembutal injections after 1/2, 1, 2 and 4hrs. (3) Standard schedule for CRF assay Figure 3 shows the standard schedule for the assay method of CRF. After the administration of 0.2mg of dexamethasone i.p., rats were returned to individual cages and left free from all stimuli.
Two hrs. after injection, they were Endocrinol. Japon. Sept. 1966 shows the results of vasopressin administration in Nembutal or dexamethasoneNembutal treated rats. The data show that the stimulating effect of vasopressin upon ACTH release was inhibited by the treatment of 0.2mg dexamethasone if the pressor activity was kept under 80mU per rat. However, if the pressor activity reached 100mU, the plasma corticosterone concentration was significantly raised.
When rats were treated with Nembutal alone, a large increase in plasma corticosterone was observed even if a small amount of vasopressin (10mU) receptors, especially the central nervous system (Guillemin et al., 1958; Barrett and Stockham, 1963) . Therefore, the following conditions are necessary for the assay method of CRF. 1) Corticotrophic effect due to environmental stress or the effect of vairous activating drugs on the pituitary-adrenal axis must be completely blocked. 2) Corticotrophic activity of vasopressin must be suppressed as much as possible.
3) A dose-response relationship must be obtained especially for CRF, and pituitary and adrenal responsiveness must not be diminished.
4) The assay method must be easy and simple. The present paper describes the details of an assay method for CRF in the light of the above-mentioned criteria by the combined use of dexamethasone and Nembutal, On the possible significance of vasopressin in the release of ACTH, a clear answer has not been found. Nichols (1961) produced considerable evidence indicating that vasopressin itself is the ACTH-releasing neurohumor. Hearn et al.(1961) reported that synthetic lysine vasopressin has a CRF-like activity.
Furthermore, the dissociation between endogenous secretion of vasopressin and secretion of ACTH was demonstrated in hypothalamic lesioned animals with water loading (Nichols and Guillemin, 1959) . Although the role of vasopressin in the release of ACTH is still controversial, the present study clearly demonstrates that ACTH release is controlled at least by CRF, which is certainly different from vasopressin.
On the other hand, Leeman et al.(1962) stated that corticosteroid pretreatment could not be safely used in the assay for ACTH-releasing neurohumor because determination of plasma corticosterone after Pitressin showed no difference between normal and corticoid blocked animals, whereas the responses to histamine or laparotomy were prevented by corticosteroid pretreatment. They explained that Pitressin acts at a site in the central nervous system through a mechanism different from that of most other stimuli.
However, the reports of Schally et al.(1958) and of this laboratory (Ishihara and Kakegawa, 1960; Ishihara, 1963; Ishihara and Nagamachi, 1964) indicate that Pitressin is not a pure vasopressin but contains a neurohumor as a contaminant. Pitressin is separated into about three components, each of which shown oxytocic, pressor and CRF activity, by means of paper chromatography in n-buthanol/ acetic acid/water system. There is also dissociation of pressor effect on UrethaneDibenamine treated rats between synthetic lysine-8 vasopressin (Sandoz) and Pitressin (Parke-Davis). That Pitressin is 1.2 to 2.0 times as synthetic vasopressin in pressor activity was recently observed in this laboratory.
Therefore, such a comparison between two different preparations, synthetic and crude, seems to be insignificant. Moreover, still controversial is the site of the blocking action of glucocorticoids on the hypothalamo-hypophysio-adrenal axis, although it is generally accepted that the release of ACTH can be suppressed by high level of corticosteroid in the blood. Some authors suggest the negative feed-back action on the central nervous system (Porter and Jones, 1956; McCann et al., 1958; Leeman et al., 1962; Yates and Urquhart, 1962; Davidson and Feldman, 1963; Fraschini et al., 1964) , others present evidence on the anterior pituitary (Ganong and Hume, 1955, de Wied and Mirsky, 1959; Yoshida and Sayers, 1961; de Wied, 1964) and others suggest the adrenal cortex (Birmingham and Kurlents, 1958; Peron et al., 1960; Saifran and Vogt, 1960; Feket and Gogag, 1962) . It is reasonable to suppose that the blocking action of dexamethasone is located in the central nervous system, probably in the hypothalamus, although it cannot be denied that the adrenal responsiveness to endogenous or exogenous ACTH is certainly lowered when large amount of dexamethasone is administered. Further studies are needed to solve remining problems.
